{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:41:54Z","timestamp":1788090114519,"version":"build-2803163510"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,8,15]]},"DOI":"10.2169\/internalmedicine.6614-25","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T22:08:23Z","timestamp":1768428503000},"page":"2205-2209","source":"Crossref","is-referenced-by-count":1,"title":["Cytomegalovirus Colitis during Budesonide Therapy for Ulcerative Colitis"],"prefix":"10.2169","volume":"65","author":[{"given":"Kana","family":"Tamazawa","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"},{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Aizawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"},{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Ishizaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"},{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakeru","family":"Otomo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"},{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadayuki","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"},{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutomo","family":"Togashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukushima Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nakase H, Uchino M, Shinzaki S, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease 2020. J Gastroenterol 56: 489-526, 2021.","DOI":"10.1007\/s00535-021-01784-1"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Sandborn WJ, Travis S, Moro L, et al. Once-daily budesonide MMX<sup>\u00ae<\/sup> extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study. Gastroenterology 143: 1218-1226.e2, 2012.","DOI":"10.1053\/j.gastro.2012.08.003"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Travis SPL, Danese S, Kupcinskas L, et al. Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Gut 63: 433-441, 2014.","DOI":"10.1136\/gutjnl-2012-304258"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kambham N, Vij R, Cartwright CA, Longacre T. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol 28: 365-373, 2004.","DOI":"10.1097\/00000478-200403000-00009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kim YS. Does cytomegalovirus load predict the outcome of acute severe ulcerative colitis? Intest Res 19: 357-359, 2021.","DOI":"10.5217\/ir.2021.00120"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Suzaki K, Kobayashi K, Matsuoka M, et al. A case of cytomegalovirus esophagitis during topical steroid therapy for eosinophilic esophagitis. Clin J Gastroenterol 13: 1046-1050, 2020.","DOI":"10.1007\/s12328-020-01219-z"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. G\u0142\u00f3wczewski A, Krogulska A. Formulations of topical steroids in eosinophilic esophagitis - current treatment and emerging possibilities. J Clin Med 11: 1454, 2022.","DOI":"10.3390\/jcm11051454"},{"key":"8","unstructured":"8. Research Group for Intractable Inflammatory Bowel Disease. Diagnostic criteria and treatment guidelines for ulcerative colitis and Crohn&apos;s disease, FY2023. Ministry of Health, Labour and Welfare, Tokyo, 2024."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Harbord M, Eliakim R, Bettenworth D, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management. J Crohns Colitis 11: 769-784, 2017.","DOI":"10.1093\/ecco-jcc\/jjx009"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kredel LI, Mundt P, van Riesen L, et al. Accuracy of diagnostic tests and a new algorithm for diagnosing cytomegalovirus colitis in inflammatory bowel diseases: a diagnostic study. Int J Colorectal Dis 34: 229-237, 2019.","DOI":"10.1007\/s00384-018-3170-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chun J, Lee C, Kwon JE, et al. Usefulness of the cytomegalovirus antigenemia assay in patients with ulcerative colitis. Intest Res 13: 50-59, 2015.","DOI":"10.5217\/ir.2015.13.1.50"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kucharzik T, Ellul P, Greuter T, et al. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis 15: 879-913, 2021.","DOI":"10.1093\/ecco-jcc\/jjab052"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and meta-regression. Clin Gastroenterol Hepatol 5: 103-110, 2007.","DOI":"10.1016\/j.cgh.2006.09.033"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/16\/65_6614-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:11:49Z","timestamp":1786767109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/16\/65_6614-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":13,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6614-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"article-number":"6614-25"}}